secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001213900-25-123880
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio enters $65M ATM equity distribution agreement with A.G.P.
--------------------------------------------------------------------

- Up to $65M of common stock may be sold from time to time through A.G.P. as sales agent.
- Commission of 3.0% of gross proceeds; Company not obligated to sell any shares.
- Shares offered via shelf registration effective Aug 7, 2024, with prospectus supplement dated Dec 19, 2025.
- A.G.P. will use commercially reasonable efforts consistent with Nasdaq rules and state/federal law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025123880/0001213900-25-123880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025123880/ea0269963-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-123880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer